Cargando…

Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing

Infections with antimicrobial-resistant (AMR) bacteria are globally on the rise. In the future, multi-resistant infections will become one of the major problems in global health care. In order to enable reserve antibiotics to retain their effect as long as possible, broad-spectrum antibiotics must b...

Descripción completa

Detalles Bibliográficos
Autores principales: Busche, Jan F., Möller, Svenja, Stehr, Matthias, Dietzel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843207/
https://www.ncbi.nlm.nih.gov/pubmed/31614761
http://dx.doi.org/10.3390/mi10100691
_version_ 1783468160474677248
author Busche, Jan F.
Möller, Svenja
Stehr, Matthias
Dietzel, Andreas
author_facet Busche, Jan F.
Möller, Svenja
Stehr, Matthias
Dietzel, Andreas
author_sort Busche, Jan F.
collection PubMed
description Infections with antimicrobial-resistant (AMR) bacteria are globally on the rise. In the future, multi-resistant infections will become one of the major problems in global health care. In order to enable reserve antibiotics to retain their effect as long as possible, broad-spectrum antibiotics must be used sparingly. This can be achieved by a rapid microfluidic phenotypic antibiotic susceptibility test, which provides the information needed for a targeted antibiotic therapy in less time than conventional tests. Such microfluidic tests must cope with a low bacteria concentration. On-chip filtering of the samples to accumulate bacteria can shorten the test time. By means of fluorescence microscopy, we examined a novel nanogap filtration principle to hold back Escherichia coli and to perform cultivation experiments with and without antibiotics present. Microfluidic chips based on the nanogap flow principle showed to be useful for the concentration and cultivation of E. coli. With a concentration of 10(6) cells/mL, a specific growth rate of 0.013 min(−1) and a doubling time of 53 min were achieved. In the presence of an antibiotic, no growth was observed. The results prove that this principle can, in future, be used in fast and marker-free antimicrobial susceptibility testing (AST).
format Online
Article
Text
id pubmed-6843207
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68432072019-11-25 Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing Busche, Jan F. Möller, Svenja Stehr, Matthias Dietzel, Andreas Micromachines (Basel) Article Infections with antimicrobial-resistant (AMR) bacteria are globally on the rise. In the future, multi-resistant infections will become one of the major problems in global health care. In order to enable reserve antibiotics to retain their effect as long as possible, broad-spectrum antibiotics must be used sparingly. This can be achieved by a rapid microfluidic phenotypic antibiotic susceptibility test, which provides the information needed for a targeted antibiotic therapy in less time than conventional tests. Such microfluidic tests must cope with a low bacteria concentration. On-chip filtering of the samples to accumulate bacteria can shorten the test time. By means of fluorescence microscopy, we examined a novel nanogap filtration principle to hold back Escherichia coli and to perform cultivation experiments with and without antibiotics present. Microfluidic chips based on the nanogap flow principle showed to be useful for the concentration and cultivation of E. coli. With a concentration of 10(6) cells/mL, a specific growth rate of 0.013 min(−1) and a doubling time of 53 min were achieved. In the presence of an antibiotic, no growth was observed. The results prove that this principle can, in future, be used in fast and marker-free antimicrobial susceptibility testing (AST). MDPI 2019-10-12 /pmc/articles/PMC6843207/ /pubmed/31614761 http://dx.doi.org/10.3390/mi10100691 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Busche, Jan F.
Möller, Svenja
Stehr, Matthias
Dietzel, Andreas
Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title_full Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title_fullStr Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title_full_unstemmed Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title_short Cross-Flow Filtration of Escherichia coli at a Nanofluidic Gap for Fast Immobilization and Antibiotic Susceptibility Testing
title_sort cross-flow filtration of escherichia coli at a nanofluidic gap for fast immobilization and antibiotic susceptibility testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843207/
https://www.ncbi.nlm.nih.gov/pubmed/31614761
http://dx.doi.org/10.3390/mi10100691
work_keys_str_mv AT buschejanf crossflowfiltrationofescherichiacoliatananofluidicgapforfastimmobilizationandantibioticsusceptibilitytesting
AT mollersvenja crossflowfiltrationofescherichiacoliatananofluidicgapforfastimmobilizationandantibioticsusceptibilitytesting
AT stehrmatthias crossflowfiltrationofescherichiacoliatananofluidicgapforfastimmobilizationandantibioticsusceptibilitytesting
AT dietzelandreas crossflowfiltrationofescherichiacoliatananofluidicgapforfastimmobilizationandantibioticsusceptibilitytesting